跳至主要内容
临床试验/NCT07268209
NCT07268209已完成不适用

Validation of a Score for Supplementation Needs of Vitamins, Micronutrients and Proteins After Bariatric Surgery

Hospital Universitari de Bellvitge1 个研究点 分布在 1 个国家目标入组 4,514 人开始时间: 2024年6月12日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
4,514
试验地点
1
主要终点
Score coherence

研究概览

简要总结

ABSTRACT Obesity is, nowadays, a pandemic. The treatment of patients affected by obesity is very complex and requires the synergy of a multidisciplinary team that addresses the problem in its different spheres. Among the available treatment options, surgery remains the most effective in the long term. Among surgical techniques, there are different types based on different mechanisms. Among them, hypoabsorptive techniques, which are the most effective, can lead to malnutrition and vitamin deficiencies, so the creation of a standardized score -similar to Clavien-Dindo- could be a simple, reproducible tool with sufficient clinical relevance to allow comparison of nutritional outcomes between different surgical techniques.

Hypothesis: The BARSCORE score will allow estimation of supplementation needs for vitamins, micronutrients and proteins after bariatric surgery.

Objectives: To validate a score in bariatric surgery that grades supplementation needs by relating them to patient characteristics and the proposed surgical technique.

Methodology: observational, longitudinal, multicenter study. The study sample will consist of patients who underwent bariatric surgery between January 2015 and December 2021 in participating centers (Appendix 1).

Patients will be divided into three groups based on the surgery performed and the score will be applied. Subsequently, surveys will be conducted to evaluate the score and cases for applying the score.

For statistical analysis, Spearman's correlation test will be used to verify the consistency of the score and a two-way ANOVA analysis to measure its concordance.

详细描述

INTRODUCTION Morbid obesity is considered the great epidemic of this century. It is the leading cause of non-traumatic death in the Western population and is progressively affecting developing countries. In the latest epidemiological studies, it is estimated that in Spain more than 15% of the population is overweight, and approximately 5% suffer from morbid obesity.

The treatment of morbid obesity is multidisciplinary, ranging from changes in lifestyle habits and diet to surgery. Among all available therapeutic options, bariatric surgery is the only cost-effective long-term treatment for patients with morbid obesity. It offers better results than pharmacological treatments and lifestyle changes. Furthermore, it has been shown to reduce and improve comorbidities, improve quality of life, reduce the risk of cardiovascular diseases and mortality, and improve quality of life.

There are currently several standardized bariatric surgical techniques. These techniques can be restrictive such as vertical gastrectomy (VG), hypoabsorptive such as duodenal switch (DS) and single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S), or mixed such as gastric bypass (GBP). Their indication will depend on factors such as the patient's BMI, metabolic comorbidities, or the surgical team's experience, among others. All of them have proven to be safe in experienced teams, with mortality rates equal to or less than 0.5% and morbidity less than 10%.

Although postoperative risks are low, they must be considered along with the potential benefits of surgery on an individual basis and as accurately as possible in each case. This allows the decision to perform surgery to be made consensually with the patient based on objective data.

One of the main risks, especially of mixed and hypoabsorptive techniques, is the risk of malnutrition and vitamin deficiencies. This complication is recorded in the literature in a heterogeneous and non-comparable manner. Articles documenting levels of nutrients, vitamins, and trace elements in blood during follow-up after bariatric surgery are complex to assess since data collection is not performed in a standardized way and it is not specified whether blood levels are with or without supplementation or the supplementation dose received; making them non-uniform and difficult to compare with each other.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients operated on for primary laparoscopic bariatric surgery using vertical gastrectomy, gastric bypass, duodenal switch, or single-anastomosis duodenal switch (SADI-S)
  • Techniques between 2015 and 2022 in participating centers.
  • Minimum 2-year follow-up.
  • Analytical control and evaluation by endocrinologist and dietitian/nutritionist.

排除标准

  • Patients operated on for revisional surgery.
  • Patients operated with less frequent techniques such as single-anastomosis gastric bypass or intestinal bipartition.
  • Patients operated on via open approach or requiring conversion to open approach during surgery.
  • Patients with loss to follow-up.

结局指标

主要结局

Score coherence

时间窗: Baseline score measurement at inclusion in the study

Measure: Spearman correlation coefficient between surgical complexity and BARSCORE score (0: no supplements, I protocol, II oral supplements, III parenteral supplements, IV mild malnutrition, V severe malnutrition). Higher values of the score indicate a greater need for supplementation. Success criteria: p \<0.05

Score Concordance (reproducibility)

时间窗: Through study completion, an average of 6 months

Measure: Two-way ANOVA analysis of responses from different investigators on standardized cases. The investigators will be given a list of cases where they have to apply the BARSCORE score (0: no supplements, I protocol, II oral supplements, III parenteral supplements, IV mild malnutrition, V severe malnutrition). Success criteria: p \<0.05

Ease of Application

时间窗: Through study completion, an average of 6 months

Measure: Percentage of favorable responses in the evaluation survey Success criteria: \>70% favorable responses

次要结局

未报告次要终点

研究者

发起方
Hospital Universitari de Bellvitge
申办方类型
Other
责任方
Principal Investigator
主要研究者

Javier Osorio

Head of Esophago-gastric and Bariatric Surgery Unit

Hospital Universitari de Bellvitge

研究点 (1)

Loading locations...

相似试验